Lido Advisors, LLC Amgen Inc Transaction History

Lido Advisors, LLC

$20.3 Billion
Q3 2024

A detailed history of Lido Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lido Advisors, LLC holds 50,512 shares of AMGN stock, worth $14.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

50,512

Previous 49,256 2.55%

Holding current value

$14.9 Million

Previous $15.4 Million 5.75%

% of portfolio

0.08%

Previous 0.09%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $388,581 - $423,749	1,256 Added 2.55%	50,512 $16.3 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $6.46 Million - $7.86 Million	-24,602 Reduced 33.31%	49,256 $15.4 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.35 Million - $1.63 Million	5,016 Added 7.29%	73,858 $21 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $776,049 - $875,476	3,035 Added 4.61%	68,842 $19.8 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $5.72 Million - $7.1 Million	26,151 Added 65.94%	65,807 $17.7 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $341,546 - $403,871	1,594 Added 4.19%	39,656 $8.8 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $3.96 Million - $4.82 Million	-17,520 Reduced 31.52%	38,062 $9.2 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $5.16 Million - $6.56 Million	22,525 Added 68.14%	55,582 $14.6 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $4.79 Million - $5.4 Million	21,329 Added 181.86%	33,057 $7.45 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $323,455 - $359,949	-1,402 Reduced 10.68%	11,728 $2.85 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $82,884 - $91,691	378 Added 2.96%	13,130 $3.18 Million
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $6.1 Million - $6.98 Million	-30,658 Reduced 70.62%	12,752 $2.87 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $1.25 Million - $1.46 Million	5,878 Added 15.66%	43,410 $9.23 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $601,702 - $667,544	2,576 Added 7.37%	37,532 $9.15 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $1.15 Million - $1.34 Million	5,170 Added 17.36%	34,956 $8.7 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $4.59 Million - $5.47 Million	21,219 Added 247.68%	29,786 $6.85 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $277,121 - $308,181	1,181 Added 15.99%	8,567 $2.18 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $190,491 - $233,758	963 Added 14.99%	7,386 $1.74 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $52,667 - $69,851	-289 Reduced 4.31%	6,423 $1.3 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $325,441 - $418,304	1,720 Added 34.46%	6,712 $1.62 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $21,415 - $25,660	-123 Reduced 2.4%	4,992 $966,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $56,177 - $65,853	337 Added 7.05%	5,115 $942,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $41,780 - $47,096	-231 Reduced 4.61%	4,778 $907,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $30,684 - $35,819	172 Added 3.56%	5,009 $975,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $76,339 - $86,062	-412 Reduced 7.85%	4,837 $1 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $11,789 - $13,242	-71 Reduced 1.33%	5,249 $968,000
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $409,681 - $478,764	2,418 Added 83.32%	5,320 $907,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $64,477 - $72,041	382 Added 15.16%	2,902 $504,000
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $52,194 - $59,592	-312 Reduced 11.02%	2,520 $441,000
Q4 2016 Sep 21, 2017	BUY	N/A	2,832 New	2,832 $414,000
Q3 2016 Sep 21, 2017	SELL	N/A	-1,641 Closed	0 $0
Q2 2016 Sep 18, 2017	SELL	N/A	-4,258 Reduced 72.18%	1,641 $250,000
Q1 2016 Sep 18, 2017	BUY	N/A	5,899	5,899 $884,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Account

Lido Advisors, LLC Amgen Inc Transaction History